Cargando…

Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend

Gastric cancer (GC) is a cancer with high prevalence, and is one of the leading causes of cancer death worldwide. Metformin is a widely used hypoglycemic agent for type-2 diabetes mellitus (T2DM). Recently, metformin has drawn increasing attention in the field of cancer research for its emerging ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Wen, Liping, Zhou, Quan, He, Kuifeng, Teng, Lisong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505710/ https://www.ncbi.nlm.nih.gov/pubmed/32982447 http://dx.doi.org/10.2147/CMAR.S264032

Ejemplares similares

COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2019)

A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity
por: Kim, KyeongJin, et al.
Publicado: (2020)

Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target
por: Du, Xiaoxiao, et al.
Publicado: (2020)

SHIPping out diabetes—Metformin, an old friend among new SHIP2 inhibitors
por: Lehtonen, Sanna
Publicado: (2019)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways
por: Wang, Haiyong, et al.
Publicado: (2017)

Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
por: Lu, Jun, et al.
Publicado: (2015)

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
por: He, Kuifeng, et al.
Publicado: (2012)

LncRNA UCA1 in anti-cancer drug resistance
por: Wang, Haohao, et al.
Publicado: (2017)

Metformin: An Old Drug with New Applications
por: Zhou, Joseph, et al.
Publicado: (2018)

Perioperative metformin: Friend or foe
por: Nair, Abhijit S.
Publicado: (2020)

Giant appendiceal neurofibroma in von Recklinghausen’s disease: A case report and literature review
por: GUO, LIWEN, et al.
Publicado: (2014)

A new model for an old friend
por: Sedwick, Caitlin
Publicado: (2017)

An old friend turned foe: Metformin‐induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia
por: Sharma, Avirale, et al.
Publicado: (2021)

An Old Friend
Publicado: (1921)

The Hygiene Hypothesis, Old Friends, and New Genes
por: Frew, John W.
Publicado: (2019)

Hepatocellular carcinoma: old friends and new tricks
por: Kim, Eunsun, et al.
Publicado: (2020)

The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
por: Drzewoski, Józef, et al.
Publicado: (2021)

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
por: Hostalek, Ulrike, et al.
Publicado: (2015)

The old man’s friend
por: Rijkers, Ger T., et al.
Publicado: (2018)

COVID-19 and diabetes: Is metformin a friend or foe?
por: Ursini, Francesco, et al.
Publicado: (2020)

Molecular mechanism of action of metformin: old or new insights?
por: Rena, Graham, et al.
Publicado: (2013)

Metformin and Autoimmunity: A “New Deal” of an Old Drug
por: Ursini, Francesco, et al.
Publicado: (2018)

New use for an old drug: Metformin and atrial fibrillation
por: Vinciguerra, Manlio, et al.
Publicado: (2022)

Aging microglia: old friends greet new enemies
por: Dong, Yifei, et al.
Publicado: (2022)

Carcinosarcoma of the stomach with alpha-fetoprotein-producing hepatoid adenocarcinoma: an unexpected combination of two rare subtypes of gastric cancer in one tumor
por: Li, Zhongqi, et al.
Publicado: (2021)

The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?
por: Peng, Ye, et al.
Publicado: (2021)

PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study
por: Chen, Yiran, et al.
Publicado: (2022)

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021)

Metformin and Prostate Cancer: a New Role for an Old Drug
por: Whitburn, Jessica, et al.
Publicado: (2017)

Helicobacter pylori and gastroduodenal pathology: New threats of the old friend
por: Ahmed, Niyaz, et al.
Publicado: (2005)

Probiotic therapy - recruiting old friends to fight new foes
por: Sleator, Roy D
Publicado: (2010)

Special Issue “Equine Viruses”: Old “Friends” and New Foes?
por: Paillot, Romain
Publicado: (2020)

Sodium Channels and Local Anesthetics—Old Friends With New Perspectives
por: Körner, Jannis, et al.
Publicado: (2022)

Activation induced cytidine deaminase: An old friend with new faces
por: Çakan, Elif, et al.
Publicado: (2022)

Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer
por: Gu, Yu, et al.
Publicado: (2016)

Old Friends.—Regularity of Life
Publicado: (1855)

Old Friends, Old Wine, and Old COPD Classification Are Best
por: Rhee, Chin Kook
Publicado: (2018)

Interactions between gastric microbiota and metabolites in gastric cancer
por: Dai, Daofeng, et al.
Publicado: (2021)

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
por: Yu, Xiongfei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_521nm88lm2afq67vlggig829sk